Last reviewed · How we verify

NCT05999123

Menstrual Cycle Study

Completed Last updated 20 December 2024
What this trial tests

trial in Menstruation in 143 participants. Completed in 30 August 2024.

Timeline
25 July 2023
Primary endpoint
30 August 2024
30 August 2024

Quick facts

Lead sponsorFitbit LLC
StatusCompleted
Study typeOBSERVATIONAL
Enrollment143
Start date25 July 2023
Primary completion30 August 2024
Estimated completion30 August 2024
Sites1 location across United States

Conditions studied

Sponsor

Fitbit LLC

Who can join

Adults 18 to 42, female only, with Menstruation or Ovulation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A data collection study to develop algorithms to estimate menstrual cycle phases.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Menstruation

Currently open trials in the same condition.

Other Fitbit LLC trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05999123.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing